Intravitreal Infliximab for Diabetic Macular Edema (DME) and Choroidal Neovascularization (CNV)

NCT00695682 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

4

Enrollment

OTHER

Sponsor class

Conditions

Diabetic Retinopathy
Macular Degeneration

Interventions

DRUG: intravitreal injection of infliximab

Sponsor

Retina Research Foundation